| Date | Form | Description | Docs | XBRL | Pages |
| 02/27/04 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
24 | |
| 02/25/04 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/25/04 | 4 | Statement of changes in beneficial ownership of securities |
|
3 | |
| 12/22/03 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
51 | |
| 12/15/03 | 5 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/15/03 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
21 | |
| 06/16/03 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
20 | |
| 05/16/03 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
3 | |
| 05/16/03 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
3 | |
| 05/08/03 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat
Read More...Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation
Read More...Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization
Read More...